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ABSTRACT 1 
 2 
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease caused by defective 3 
prelamin-A processing, leading to nuclear lamina alterations, severe cardiovascular pathology, 4 
and premature death. Prelamin-A alterations also occur in physiological aging. It remains 5 
unknown how defective prelamin-A processing affects the cardiac rhythm. We demonstrate 6 
age-dependent cardiac repolarization abnormalities in HGPS patients that are also present in the 7 
Zmpste24-/- mouse model of HGPS. Challenge of Zmpste24-/- mice with the β-adrenergic 8 
agonist isoproterenol did not trigger ventricular arrhythmia but caused bradycardia-related 9 
premature ventricular complexes and slow-rate polymorphic ventricular rhythms during 10 
recovery. Patch-clamping in Zmpste24-/- cardiomyocytes revealed prolonged calcium-transient 11 
duration and reduced sarcoplasmic reticulum calcium loading and release, consistent with the 12 
absence of isoproterenol-induced ventricular arrhythmia. Zmpste24-/- progeroid mice also 13 
developed severe fibrosis-unrelated bradycardia and PQ interval and QRS complex 14 
prolongation. These conduction defects were accompanied by overt mislocalization of the gap-15 
junction protein connexin43 (Cx43). Remarkably, Cx43 mislocalization was also evident in 16 
autopsied left ventricle tissue from HGPS patients, suggesting intercellular connectivity 17 
alterations at late stages of the disease. The similarities between HGPS patients and progeroid 18 
mice reported here strongly suggest that defective cardiac repolarization and cardiomyocyte 19 
connectivity are important abnormalities in the HGPS pathogenesis that increase the risk of 20 
arrhythmia and premature death. 21 
 22 
KEYWORDS: Hutchinson-Gilford progeria syndrome / progerin / prelamin A/ connexin43 / 23 
intercellular connectivity / calcium handling / ventricular rhythm. 24 
 25 
 26 
 27 
 28 
  29 
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SIGNIFICANCE 1 
 2 
 3 
Defective prelamin A processing causes cardiovascular alterations and premature death in 4 
HGPS patients, and also occurs during physiological aging. We found overt repolarization 5 
abnormalities in HGPS patients at advanced disease stages. Similar alterations were present in 6 
progeroid Zmpste24-/- mice, whose cardiomyocytes exhibited prolonged calcium transient 7 
duration and reduced sarcoplasmic reticulum calcium loading capacity and release, consistent 8 
with absence of isoproterenol-induced ventricular arrhythmias. Zmpste24-/- mice developed 9 
age-dependent bradycardia and PQ interval/QRS complex prolongation, likely contributing to 10 
premature death. These defects correlated with mislocalization of connexin43, which was also 11 
noted in heart tissue from HGPS patients. These results reveal molecular alterations that might 12 
cause cardiac rhythm alterations and premature death in HGPS. 13 
 14 
 15 
  16 
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\body 1 
 2 
INTRODUCTION 3 
 4 
The LMNA gene encodes A-type lamins (lamin A and lamin C), key components of the 5 
mammalian nuclear envelope with important structural and regulatory functions that affect 6 
signaling, transcription, and chromatin organization, among other processes (1). Mature lamin 7 
A is produced from the precursor prelamin A through a series of posttranslational 8 
modifications, consisting of sequential farnesylation at the cysteine in the CSIM motif, 9 
cleavage of the SIM residues, carboxymethylation of the newly accessible cysteine, and a final 10 
proteolytic cleavage by the zinc metalloprotease ZMPSTE24/FACE-1 (2). 11 
Mutations in the human LMNA gene or defective processing of prelamin A cause a group of 12 
diseases termed laminopathies, including the premature aging disorder Hutchinson-Gilford 13 
progeria syndrome (HGPS) (OMIM #176670), a very rare genetic disorder with an estimated 14 
prevalence of 1 in 21 million people (http://www.progeriaresearch.org/). HGPS patients exhibit 15 
accelerated atherosclerosis and arterial stiffness, leading to premature death at an average age 16 
of 14.6 years, predominantly from myocardial infarction, heart failure or stroke (3, 4). Most 17 
HGPS patients carry a non-inherited de novo heterozygous synonymous mutation at codon 608 18 
in LMNA (c.1824C>T: GGC>GGT; p.G608G), which activates the use of an internal 5’ 19 
splicing site in exon 11 that causes the synthesis of progerin. This unprocessed form of 20 
prelamin A lacks 50 aminoacids encompassing the ZMPSTE24 cleavage site and therefore 21 
remains permanently farnesylated (2). ZMPSTE24 mutations have also been linked to several 22 
other human progeroid syndromes (5, 6), reinforcing the notion that accumulation of progerin 23 
or prelamin A accelerates cellular aging. Moreover, progerin and prelamin A are both 24 
expressed in cells and tissues of normally aging non-HGPS individuals, suggesting their 25 
involvement in physiological aging (reviewed in (2, 7)).  26 
Genetically-modified mice expressing prelamin A or progerin have enabled the study of 27 
mechanisms underlying progeria (8) and testing of the efficacy of various therapies (9, 10). 28 
Here, we examined cardiac electrical alterations on ECGs of 15 HGPS patients with the 29 
classical LMNA c.1824C>T mutation, representing approximately 5% of the world population 30 
(www.progeriaresearch.org). We then correlated the observed alterations in HGPS patients to 31 
the underlying molecular processes in Zmpste24-null mice; these mice accumulate farnesylated 32 
prelamin A in the nuclear envelope and phenocopy several other defects observed in HGPS, 33 
including cardiovascular alterations and premature death (average lifespan ≈20 weeks versus 34 
>2 years in wild-type mice) (9, 11).   35 
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RESULTS 1 
Electrocardiographic alterations in HGPS patients. Supplemental Tables S1 and S2 show 2 
ECG measurements from HGPS patients carriers of the LMNA c.1824C>T mutation (N=15, 3 
age range 2-19 years) and controls (N=13, age range 4-19 years), respectively. As they aged, 7 4 
patients showed overt repolarization abnormalities in at least one ECG that were compatible 5 
with coronary artery disease (ST depression/elevation, negative and biphasic T waves; 6 
representative example in SI Appendix, Fig.S1A). One patient showed significant QTc interval 7 
prolongation (537 ms) in the context of ischemia at advanced stages of the disease (18 years of 8 
age). These ECG alterations were not observed in controls (representative example in SI 9 
Appendix, Fig.S1B). Repolarization abnormalities in HGPS patients were highly evident at 10 
advanced disease stages. Compared with age-matched controls, HGPS patients exhibited 11 
significant T-wave flattening which was exacerbated as disease progressed (Fig.1A, First: initial 12 
ECG; Last: last ECG during follow-up). All patients and controls had sinus rhythm and 13 
normal PR interval and QRS complex duration (SI Appendix, Tables S1 and S2). 14 
Interestingly, although all HGPS patients exhibited cardiac rhythm within physiological values, 15 
the heart rate and PR interval tended to be slower and larger, respectively, in older HGPS 16 
patients (6 out of 15) at the end of the follow-up period (26.8±2.3 months follow-up): heart rate 17 
on first and last ECG were 114±7 bpm and 101±7 bpm, respectively, p=0.36; PR on first and 18 
last ECG were 115±2 ms and 128±11 ms, respectively, p = 0.22).  19 
 20 
Time-course of ECG abnormalities in progeroid Zmpste24-/- mice. We next analyzed the 21 
electrocardiographic phenotype of Zmpste24-/- mice, an established preclinical model of HGPS 22 
(9, 11). A glossary of electrocardiographic parameters can be found in the online supplement. 23 
To study repolarization, we quantified T-wave flattening by measuring T-wave morphology 24 
changes, including sharpness, by excess kurtosis of the T-wave peak in relation to its 25 
geometrical change from the isoelectric line and the area under the T wave (see Supplemental 26 
Methods). Similarly to HGPS patients, progeroid mice showed repolarization abnormalities 27 
manifested as significant T- wave flattening. To determine the risk of ventricular arrhythmia 28 
associated with T-wave alterations we used the ß-adrenergic agonist isoproterenol, which can 29 
trigger calcium-related alterations in cardiac repolarization. Weekly isoproterenol challenge, 30 
based on its sympathomimetic effect and ability to induce Ca2+-related alterations in 31 
repolarization, further exacerbated the repolarization alterations as Zmpste24-/- mice aged, 32 
although acute isoproterenol did not cause significant ventricular arrhythmias in Zmpste24-/- or 33 
controls (Fig.1B). While both groups responded normally in the first week of follow-up, older 34 
Zmpste24-/- mice developed a very marked reduction in the heart rate (bradycardia) during 35 
recovery from isoproterenol (Fig.2A). In addition, compared with wild-type controls, 36 
Zmpste24-/- mice p r o g r e s s i v e l y  developed l o n g e r  RR intervals a s  t h e y  a g e d  37 
(Fig.2B,C). The variability of the RR interval, measured as the standard deviation (SD-RR), 38 
increased linearly as a function of the average RR interval (SI Appendix, Fig.S2) and was 39 
associated with increased incidence of premature ventricular complexes (PVCs, Fig.2D, and 40 
SI Appendix, Fig.S3) and a short life span. During both isoproterenol challenge (SI 41 
Appendix, Fig.S4) and recovery (SI Appendix, Fig.S5), Zmpste24-/- mice showed increased 42 
prolongation of PQ and QRS intervals. Progeroid Zmpste24-/- mice also developed age-43 
dependent bradycardia in the absence of isoproterenol (Fig.3A). In addition, at 18-20 weeks of 44 
age, Zmpste24-/- mice showed significant signs of defective cardiac conduction compared with 45 
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age-matched controls, manifested as prolonged PQ interval and QRS complex, without 1 
alterations to the QTc interval (Fig.3B-E, Supplemental Table S3). 2 
 3 
Preserved cardiac function in Zmpste24-/- mice. Transthoracic echocardiography revealed no 4 
abnormalities in left ventricle end-diastolic (LVIDs) or end-systolic (LVIDds) parameters in 5 
progeroid Zmpste24-/- mice (Fig.3F). Likewise, Zmpste24-/- mice had normal left ventricle mass, 6 
posterior wall and interventricular septal thickness at diastole (SI Appendix, Fig.S6A), and 7 
diastolic function, but had a slightly higher left ventricle ejection fraction (EF) and fractional 8 
shortening (FS) than controls (Fig.3F, and SI Appendix, Fig.S6A), although within the normal 9 
range. The higher ejection fraction in progeriod mice might be explained by bradycardia, since 10 
longer diastolic intervals may favor such an increase. In fact, together bradycardia and smaller 11 
body surface area in Zmpste24-/- mice explain the significantly lower cardiac output compared 12 
to wild-type controls (SI Appendix, Fig.S6B). However, cardiac index, which relates the 13 
cardiac output of the left ventricle per minute to body surface area, was not different between 14 
progeroid and wild-type mice (SI Appendix, Fig.6B). Time-course studies demonstrated no 15 
between-genotype differences in systolic or diastolic blood pressure (SI Appendix, Fig.S6C).  16 
 17 
Ex-vivo cellular electrophysiology. We next conducted electrophysiology studies in cardiac 18 
multicellular preparations from Zmpste24-/- mice to identify potential mechanisms underlying 19 
the arrhythmia risk associated with abnormal repolarization. No significant between-genotype 20 
differences were found in resting membrane potential (RMP), action potential amplitude 21 
(APA), maximum velocity of depolarization (Vmax), or action potential (AP) duration in right or 22 
left ventricular samples (SI Appendix, Table S4). Moreover, APs recorded in right and left 23 
ventricular preparations were indistinguishable between genotypes (Fig.4A). Interestingly, 24 
most Zmpste24-/- ventricular preparations exhibited slow spontaneous automatic activity at ≈3 25 
Hz (Fig.4B). Moreover, Zmpste24-/- left ventricle preparations displayed after-depolarizations 26 
that led to triggered APs, contrasting with normal AP in controls (Fig.4B, 4C).  27 
We next analyzed transcription of genes encoding ion channel proteins involved in the different 28 
phases of the AP. Real-time qPCR analysis in Zmpste24-/- hearts revealed no significant 29 
between-group differences in mRNA expression of Scn5A (encoding the cardiac sodium 30 
channel NaV1.5, involved in cell depolarization) or of Kcna5, Kcnj2, Kcnd3, and Kcnq1 31 
(respectively encoding the potassium channels Kv1.5, Kir2.1, Kv4.3 and Kv7.1, all involved in 32 
AP repolarization); in contrast, Zmpste24-/- hearts showed significant upregulation of Kcnh2 33 
(encoding the potassium channel Kv11.1, also known as hERG, involved in AP repolarization) 34 
(SI Appendix, Fig.S7).  35 
 36 
Zmpste24-/- mice show defective sarcoplasmic reticulum (SR) Ca2+ handling. We next 37 
investigated the role of intracellular Ca2+ handling in the observed in vivo after-depolarizations 38 
and triggered APs in multicellular left ventricle Zmpste24-/- preparations. Unlike wild-type 39 
cardiomyocytes, Zmpste24-/- cardiomyocytes were unable to maintain stable Ca2+ transients at 40 
higher stimulation frequencies, an effect that was more prominent at 5 mM extracellular Ca2+ 41 
(Fig.5A). To test whether this defect in Zmpste24-/- cardiomyocytes was caused by unstable 42 
calcium release from the SR through the ryanodine receptor type 2 (RyR2) channel, we 43 
measured the frequency of spontaneous calcium waves at rest. However, we found no 44 
differences in the calcium wave frequency at any of the calcium concentrations examined (Fig 45 
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5B). In line with these results, Zmpste24 deficiency did not affect the transcript level of RyR2 1 
(Fig.5C), which is responsible for calcium release from the SR (12). 2 
These findings suggested possible impairment of L-type Ca2+ currents (ICa) or Ca2+ uptake by 3 
the SR in Zmpste24-/- cardiomyocytes as alternative causes for unstable calcium transients. 4 
Compared with wild-type controls, Zmpste24-/- hearts expressed significantly lower transcript 5 
and protein levels of SR Ca2+ ATPase (SERCA2a), whereas there was no alteration in 6 
transcript levels of STIM1 and Orai1, essential regulators of Ca2+ release-activated Ca2+ 7 
channels (Fig.5C, 5D). We also analyzed the expression of calsequestrin 1 (CSQ1) and 2 8 
(CSQ2), calcium-binding proteins of the SR that help this organelle store a very high amount of 9 
Ca2+ during relaxation in each contraction-relaxation cycle. Although CSQ1 and CSQ2 10 
transcript levels were significantly lower in Zmpste24-/- hearts (Fig.5C), no between-genotype 11 
differences were observed at the protein level (Fig.5D). Likewise, peak ICa did not differ 12 
significantly between cardiomyocytes of the two genotypes (SI Appendix, Fig.S8). 13 
To determine SR Ca2+ reloading function in ventricular cardiomyocytes, we loaded the SR by 14 
exposing cells to an increasing number of stimulation pulses and estimated the resulting Ca2+ 15 
load from caffeine-elicited inward current traces (Fig.6A). SR reloading function was 16 
significantly weaker in Zmpste24-/- cardiomyocytes than in wild-type cells after 5, 10, and 20 17 
stimulation pulses (Fig.6B), and the defective response was still more apparent after ≥30 18 
stimulation pulses (Fig.6C). Significantly lower SR Ca2+ loading in Zmpste24-/- cardiomyocytes 19 
was also evident from caffeine-elicited current traces recorded after loading the SR by 20 
depolarizing the membrane potential for 5s to -40, -30, -20, or 0 mV (Fig.6D, 6E). In addition, 21 
intracellular Ca2+ transients recorded in isolated cardiomyocytes paced at 0.5 Hz revealed a 22 
significantly longer Ca2+-transient duration (at half maximal amplitude) in Zmpste24-/- cells 23 
(Fig.6F). 24 
Finally, we measured the SR Ca2+ release-dependent inactivation of the ICa in response to 25 
consecutive stimulation pulses given after clearance of SR Ca2+ (Fig.7A) in order to assess the 26 
feedback of SR calcium release on ICa inactivation. As expected, current traces recorded in 27 
wild-type cardiomyocytes showed a faster rate of ICa inactivation as the number of pulses used 28 
for SR reload increased from 1 (p1) to 30 (p30) (Fig.7B). In contrast, the effect of SR loading 29 
on the ICa inactivation rate in Zmpste24-/- cardiomyocytes was very modest (Fig.7B). 30 
Accordingly, the time constant for ICa inactivation decreased progressively with increasing 31 
pulse number in wild-type but not Zmpste24-/- cardiomyocytes (Fig.7C). Moreover, the 32 
amplitude of the intracellular Ca2+ transient induced by repeated stimulation at 0.5 Hz was 33 
significantly lower in Zmpste24-/- cardiomyocytes (Fig.7D). Together these findings indicate 34 
that SR Ca2+ uptake and release are blunted in Zmpste24-/- cardiomyocytes, which also explains 35 
the failure of acute isoproterenol treatment to induce ventricular arrhythmia despite abnormal 36 
repolarization. 37 
 38 
 39 
Abnormal connexin43 (Cx43) localization in the hearts of Zmpste24-/- mice and HGPS 40 
patients. To further investigate conduction alterations in progeria, we performed 41 
immunohistopathological studies in heart tissue. Cardiomyocyte size was estimated by 42 
quantifying their cross-sectional area in heart sections, as well as the membrane capacitance, 43 
which is linearly proportional to the plasma membrane area and cell size. Because Zmpste24-/- 44 
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mice are smaller than age-matched controls (9, 11), we normalized results by tibia length. 1 
Normalized cross-sectional area and membrane capacitance were similar in cardiomyocytes of 2 
both genotypes (SI Appendix, Fig. S9). We also performed Mallory’s trichrome staining, 3 
which revealed normal chambers, ventricular walls, and myocardial fiber arrangement in 4 
Zmpste24-/- hearts (SI Appendix, Fig.S10A, B). Moreover, Mallory’s trichrome staining did 5 
not reveal increased fibrosis in the ventricular interstitium (SI Appendix, Fig.S10B) or in key 6 
structures involved in cardiac conduction such as the atrioventricular node and the main His 7 
bundles (SI Appendix, Fig.S10C), which might have explained conduction abnormalities in 8 
Zmpste24-/- mice. However, consistent with previous studies in HGPS patients (13), Zmpste24-/- 9 
mice showed extensive fibrosis in the tunica media of the major coronary arteries (SI 10 
Appendix, Fig.S11A), and discontinuous and weak expression of smooth muscle actin within 11 
the medial arterial layer (SI Appendix, Fig.S11B).  12 
Another possible explanation for the observed cardiac conduction anomalies is altered 13 
expression of intercalated disc proteins that play a key role in intercellular connectivity, such as 14 
the gap junction protein Cx43 and plakoglobin, as well as cytoskeletal desmosome-interacting 15 
proteins such as desmin, a class-III intermediate filament connected to A-type lamins through 16 
Nesprin/Sun protein complexes. Western blot analysis in progeroid hearts revealed a significant 17 
≈2-fold increase in Cx43 expression without changes in plakoglobin or desmin (SI Appendix, 18 
Fig.S12). Remarkably, compared with wild-type controls, Zmpste24-/- cardiomyocytes 19 
exhibited marked mislocalization of Cx43 to the cytoplasm and the lateral long axis, as 20 
revealed by double immunofluorescence to simultaneously detect Cx43 and N-Cadherin 21 
(Fig.8A). Quantification of digital images revealed less Cx43/N-Cadherin colocalization in the 22 
hearts of progeroid mice than in wild-type controls (Fig. 8E). 23 
Profound Cx43 mislocalization was also revealed by immunostaining of left ventricle 24 
specimens obtained from two HGPS patients at autopsy. In these patients, Cx43 was 25 
abundantly associated with the perinuclear rim (Fig.8B-D), which is its trafficking origin for 26 
subsequent targeting to the intercalated disks (14) (see Discussion). Quantification of digital 27 
images confirmed a low percentage of Cx43/N-Cadherin co-localization in HGPS hearts 28 
(Fig.8E). Defective cardiomyocyte connectivity associated to Cx43 mislocalization may 29 
contribute to cardiac conduction defects in progeria (see Discussion). 30 
 31 
 32 
 33 
DISCUSSION 34 
 35 
 36 
HGPS is a devastating genetic disease resulting from abnormal processing of prelamin-A which 37 
is characterized by premature cardiovascular disease and death at an average age of 14.6 years 38 
(4). Here, we provide a comprehensive analysis of ECG abnormalities and underlying 39 
molecular changes at different stages of HGPS. Our findings may have implications for the risk 40 
of premature death in HGPS patients and potentially for normal aging, since defective prelamin 41 
A processing has also been revealed in cells and tissues of normally-aging non-HGPS 42 
individuals (reviewed in (2, 7)). A previous study identified repolarization abnormalities in 3 43 
out of 15 HGPS patients with the ‘classical’ LMNA c.1824C>T mutation (3). Here, we confirm 44 
and extend these findings through a rigorous examination of a new cohort of 15 HGPS patients 45 
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carrying the same mutation Half of the patients showed overt repolarization abnormalities in at 1 
least one ECG compatible with coronary artery disease (ST depression/elevation, negative and 2 
biphasic T waves). Repolarization abnormalities in HGPS patients were strongly evident at 3 
advanced disease stages. We also detected prominent mislocalization of Cx43 in left ventricle 4 
specimens obtained at autopsy from diseased HGPS patients; Cx43 mislocalization was also 5 
observed in the hearts of progeroid Zmpste24-/- mice, and is indicative of defective cardiac 6 
conduction in progeria (see below).   7 
Animal models resembling the clinical phenotype of HGPS patients are central to 8 
understanding the underlying mechanisms of the disease and to developing novel therapies. 9 
Our analysis of the well-established Zmpste24-/- mouse model of progeria caused by prelamin A 10 
accumulation (9, 11) revealed the progressive development of cardiac rhythm alterations that 11 
can lead to premature death. Zmpste24-/- hearts and cardiomyocytes showed the following 12 
specific alterations: i) T-wave repolarization abnormalities, which were also present in half of 13 
HGPS patients; ii) prolonged PQ interval and wide QRS complex; iii) development of 14 
bradycardia-related premature ventricular complexes and slow-rate polymorphic ventricular 15 
rhythms at late disease stages in the absence of ventricular arrhythmias during isoproterenol 16 
challenge; iii) automatic spontaneous ventricular activity and after-depolarizations ex vivo, 17 
which were associated with significantly slowed ICa inactivation and reduced amplitude of the 18 
intracellular Ca2+ transient; and iv) mislocalization of Cx43 in the heart. 19 
Notably, some characteristics of the progeroid Zmpste24-/- mouse heart are also present in 20 
HGPS patients and are frequently observed in normal aging; these include extensive fibrosis 21 
and loss of smooth muscle cells in coronary arteries, defective calcium homeostasis, 22 
progressive development of repolarization defects, and Cx43 mislocalization (15-17). Overt 23 
repolarization abnormalities in ST-T waves and T-wave flattening in mice did not increase the 24 
risk of isoproterenol-triggered ventricular arrhythmia. However, T-wave alterations are well 25 
known to increase the risk of lethal ventricular arrhythmias during ischemia (18), which might 26 
contribute to premature death in HGPS patients from myocardial infarction, one of the main 27 
causes of death in this population. T-wave abnormalities might be explained at least in part by 28 
an altered repolarization pattern brought about by two opposing ion channel changes observed 29 
in the hearts of Zmpste24-/- mice: on the one hand, the significant upregulation of Kcnh2, which 30 
encodes the hERG channel responsible for IKr, would help terminate the action potential plateau 31 
and shorten repolarization (19); on the other hand, the observed slow ICa inactivation would 32 
tend to prolong the plateau and delay repolarization (20). Importantly, an abnormally long QTc 33 
interval was observed in only one of 51 ECGs from the 15 HGPS patients, and occurred in the 34 
context of ischemia and significant repolarization anomalies. Consistently, we observed no 35 
significant QTc prolongation in Zmpste24-/- mice, in agreement with the normal APD observed 36 
in Zmpste24-/- ventricular cardiomyocytes and the majority of ECG traces from HGPS patients. 37 
Although we documented significant QRS complex widening in progeroid mice, it is important 38 
to note that the high-amplitude QRS complex in the mouse ECG represents not only the spread 39 
of depolarization across the ventricle, but also the early phase of repolarization (21). We 40 
therefore carefully examined QRS complex and QT duration (QT90, Fig.3B-E) to detect any 41 
significant increases in both parameters. However, mouse and human QT intervals must be 42 
compared with caution. 43 
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The occurrence of bradycardia-related premature ventricular complexes in Zmpste24-/- mice 1 
during recovery after isoproterenol demonstrates a significant suppression of normal pacemaker 2 
activity, with emergence of ventricular ectopic escape discharges. Isoproterenol-induced heart 3 
rate increase in vivo is associated with increases in intracellular Na+ and Ca2+ concentration 4 
(22); these changes, in the presence of the post-isoproterenol-induced bradycardia, likely 5 
contributed to the escape discharges and premature ventricular complexes arising from the 6 
Purkinje system (SI Appendix, Fig.S3). Our ex-vivo experiments with multicellular ventricular 7 
preparations showed after-depolarizations during spontaneous ventricular activity at ≈3 Hz, 8 
which is similar to the cycle length after isoproterenol treatment in vivo. Although we were 9 
unable to establish the exact origin of these ventricular after-depolarizations, the in vivo data 10 
support involvement of the Purkinje system, consistent with slow idioventricular discharges 11 
(cycle length=266.38, SI Appendix, Fig.S3) arising from varying Purkinje locations. 12 
Connexins are the pore-forming subunits of gap junctions and are essential for proper 13 
intercellular electrical coupling between cardiomyocytes and for AP spread during each cardiac 14 
cycle (23, 24). Cx43 is the major connexin expressed in the ventricles. Its abnormal expression, 15 
typically involving downregulation and heterogeneous redistribution to the lateral 16 
cardiomyocyte membrane, is associated with different forms of chronic heart disease 17 
(hypertrophic, dilated, and ischemic cardiomyopathy) and even with aging (24-26). Defective 18 
Cx43 expression results in electrical defects in the myocardium and contributes to 19 
arrhythmogenesis. Therefore, Cx43 mislocalization in the heart may explain, at least partly, the 20 
prolongation of PQ interval and QRS complex in Zmpste24-/- mice. Interestingly, reduced gap 21 
junction coupling accompanied by Cx43 lateralization has been linked to reduced functional 22 
expression of the alpha subunit (NaV1.5) of the cardiac sodium channel at the intercalated disc 23 
(27), and the reduced sodium current is likely to have contributed to the significantly impaired 24 
atrioventricular and intraventricular conduction in Zmpste24-/- mice. Previous computer 25 
simulations (28) suggest that, even in the presence of Cx43 mislocalization and low NaV1.5 26 
expression, a normal peak ICa with slow inactivation and reduced Ca2+ transients could maintain 27 
relatively safe conduction in the ventricles of Zmpste24-/- mice, albeit at a reduced velocity. 28 
However, a high intracellular Ca2+ concentration would have compromised propagation safety 29 
and caused earlier block, as observed for reduced intercellular coupling (28). Because the 30 
intercalated disc is regarded as a functional unit, with gap junction formation requiring the 31 
presence of neighboring mechanical junctions (29), we tested the expression of desmin and 32 
plakophilin-2. However, our western blot analysis in Zmpste24-/- hearts revealed no alterations 33 
in the expression of these proteins.  34 
Consistent with the findings in Zmpste24-/- mice, immunofluorescence studies in left ventricle 35 
specimens from deceased HGPS patients revealed abnormal cellular distribution of Cx43 to a 36 
predominantly perinuclear localization. Since Cx43 is packaged into vesicles at the perinuclear 37 
trans-Golgi network and is then transported to the intercalated disk (14), our findings suggest 38 
that abnormal prelamin A processing causes defective Cx43 targeting to its distinctive 39 
microdomain at the gap junctions. Additional LMNA mutations might also cause 40 
cardiomyopathy by altering connexin expression and/or cellular localization. For example, 41 
transgenic mice expressing the lamin A N195K mutant, which causes dilated cardiomyopathy 42 
with conduction system disease in humans (DCM-CD1), die at an early age due to arrhythmia, 43 
and such a phenotype correlates with cardiac Cx43 and Cx40 misexpression and/or 44 
mislocalization (30). Future studies are warranted to elucidate the mechanism causing defective 45 
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Cx43 microdomain targeting to gap junctions and their contribution to abnormal cardiac 1 
conduction in progeria. 2 
Some of the nuclear envelope alterations in the heart associated with prelamin A or progerin 3 
expression also occur during normal aging (15-17), suggesting that shared mechanisms might 4 
cause cardiac alterations in HGPS patients and in the geriatric population. Consistent with this 5 
idea, prelamin A and progerin are both produced in the cells of normally aging individuals, thus 6 
raising the possibility that altered lamin A processing contributes to normal aging and 7 
associated cardiovascular disease (reviewed in (2, 7)). Much like in normal human aging, 8 
progeroid Zmpste24-/- mice develop coronary fibrosis, bradycardia and severe conduction 9 
abnormalities. Cardiac conduction abnormalities also arise during aging in wild-type mice, and 10 
are associated with an increased incidence of arrhythmias (31). However, Ca2+ transients differ 11 
between Zmpste24-/- mice and normally aging wild-type mice (32), with Zmpste24-/- 12 
cardiomyocytes being unable to maintain stable Ca2+ transients at 4 Hz. Ventricular 13 
cardiomyocytes from aged wild-type mice also have a significantly higher incidence of 14 
spontaneous Ca2+ sparks than cells from young animals; however, we did not observe a similar 15 
difference between progeroid mice and age-matched controls. Zmpste24-/- mice show weakened 16 
ICa inactivation and defective SR Ca2+ uptake and release, features also observed in aging 17 
human atrial myocytes (15). In line with this, Ca2+ transient amplitudes are reduced in 18 
progeroid mice (Fig.6), in aged wild-type mice (32), and in aged human atrial cardiomyocytes 19 
(15). 20 
The progressively developing bradycardia and deteriorating cardiac conduction in progeriod 21 
mice also resemble clinical rhythm abnormalities observed in the elderly (16, 17). Although the 22 
commonest age-related cardiac conduction abnormality in humans is degenerative fibrosis (33), 23 
Zmpste24-/- mice did not show abnormal fibrosis in the ventricular interstitium or in the major 24 
conduction structures. However, in line with observations in HGPS patients (13), the coronary 25 
arteries of Zmpste24-/- mice showed extensive fibrosis and reduced accumulation of smooth 26 
muscle cells, potential causes of vascular stiffening, reduced coronary flow, and abnormal 27 
impulse generation in the sinoatrial node and conduction in the atria and ventricles. The latter 28 
may have also contributed to T-wave alterations, especially during isoproterenol challenge, as 29 
well as to progressive development of bradycardia in progeroid Zmpste24-/- mice. In fact, 30 
human patients with coronary artery disease show a high prevalence of conduction 31 
abnormalities such as atrioventricular or sinoatrial block (34). 32 
Study Limitations.  We provide a comprehensive characterization of cardiac abnormalities in 33 
HGPS patients and progeroid Zmpste24-/- mice, identifying a number of cellular and molecular 34 
alterations in both species that are likely to contribute to defective cardiac repolarization and 35 
conduction in progeria. Future studies are warranted to establish direct causal connections 36 
between the presence of unprocessed prelamin A or progerin and the cardiac abnormalities 37 
associated with HGPS with the goal of identifying novel targets for therapeutic intervention. 38 
Based on our findings, major efforts should be placed into elucidating the mechanisms causing 39 
Cx43 mislocalization in the heart of progeroid mice and HGPS patients. These studies may 40 
pave the way to developing efficient therapies to improve cardiac conduction in progeria. 41 
Although ion channels are highly conserved between humans and mice, significant 42 
electrophysiological differences exist (35), making it difficult to translate mouse findings to the 43 
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clinical arena. For example, although we observed a tendency toward a slower heart rate in 1 
older HGPS patients with longer follow-up, HGPS patients did not show the bradycardia and 2 
other conduction abnormalities that appeared progressively in Zmpste24-/- mice. This might 3 
have been due to the lack of sequential ECG assessment in humans until very advanced disease 4 
stage. Indeed, human left ventricle specimens obtained by autopsy revealed reduced 5 
localization of Cx43 at gap junctions, consistent with altered ventricular conduction velocity. 6 
Continuous telemetry and other invasive electrophysiological measurements would have been 7 
desirable in Zmpste24-/- mice. However, these animals show severe body weight loss (body 8 
weight ≈9 g at late stages compared with ≈30 g in age-matched wild-type controls) and are 9 
physically extremely fragile, precluding the use of commercially available telemetry systems or 10 
any other invasive approaches to register specific arrhythmias forecasting premature death. The 11 
physical deterioration of HGPS patients also limits implementation of any invasive 12 
measurements (e.g., implantable loop recordings) to further study rhythm abnormalities.13 
13 
 
MATERIALS AND METHODS 
 
Clinical information from children with HGPS was obtained from The Progeria Research 
Foundation Medical and Research Database (PI L.B.G.), and approved by the Rhode Island 
Hospital and Brown University Institutional Review Boards (Providence, RI).  All participants 
or parents provided written informed consent in the primary language of the participant or 
parent. When appropriate, interpreters were used for consenting. At least one ECG recorded no 
more than 3 years before death was obtained from each of 15 HGPS patients. Thirteen gender 
and age-matched control volunteers were weighed and ECG traces recorded for comparison. 
All control volunteers or parents provided written informed consent. Animal studies were 
carried out in male Zmpste24-/- mice (11) and age-matched wild-type male littermates (all 
C57BL/6). Animals were reared and housed in accordance with institutional guidelines and 
regulations. All other detailed materials and methods are described in the SI Materials and 
Methods. 
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FIGURE LEGENDS 
 
FIGURE 1. Age-related exacerbation of repolarization abnormalities in HGPS patients 
and Zmpste24-/- mice. (A) Left: Extracted averaged ECG leads II and V5 from human control 
participants (blue traces) and HGPS patients at initial stage (‘First’, light red trace) and in 
advanced stages (‘Last’, dark red trace). Right: Quantification of mean flattening scores. (B) 
Left: Representative T-wave abnormalities in Zmpste24-/- mice, comparing the first and the last 
isoproterenol (ISO) challenge (First: 11-week-old; Last: 19-week-old or last week before death; 
see Supplementary Methods). Right: Mean effective flattening scores at baseline, after ISO 
exposure and during 5 min recovery. *, p<0.05 vs control; †, p<0.05 vs First follow up. 
FIGURE 2. Severe bradycardia in post-isoproterenol administration recovery is associated 
with an increase in premature ventricular complexes in Zmpste24-/- mice. (A) β-adrenergic 
response (interbeat interval, IBI) in wild-type and Zmpste24-/- mice from the first to the last 
isoproterenol challenge (ISO) (First: 11-week-old; Last: 19-week-old or last week before death. 
(B) RR histograms and RRn/RRn+1 correlation plots in wild-type and Zmpste24-/- mice during 
ISO time-course challenge (color-coded time scale). A significant increase in the percentage of 
long RR intervals during the last week of follow up (C) was also associated with a significant 
increase in bradycardia-related premature ventricular complexes. (D) First: 11-week-old; Last; 
19-week-old or last week before death. See SI Materials and Methods.  *, p<0.05; **, p<0.01. 
FIGURE 3. Zmpste24-/- mice show preserved cardiac function but develop severe 
bradycardia and cardiac conduction abnormalities. (A) Heart rate (bpm, beats per minute) 
in conscious mice. (B) Template ECG showing the intervals used to quantify (C) PQ, (D) QRS 
and (E) heart-rate-corrected QT at 90% of repolarization from Tpeak (QTc90) duration, measured 
on the baseline ECG at the first follow-up (week 11; First) and at the last follow-up (Last; see 
Supplementary Methods). (F) Left ventricular internal diameter (LVID) at systole (s) and 
diastole (d) and ejection fraction (EF) determined by trans-thoracic echocardiography in 18-20-
week-old mice. *, p<0.05; **, p<0.01; ***, p<0.001. 
FIGURE 4. Transmembrane action potentials recorded in multicellular left ventricular 
preparations. (A) Representative APs (3 Hz) from wild-type and Zmpste24-/- mice. (B) Left 
ventricular preparations from Zmpste24-/- mice displayed after-depolarizations that occasionally 
yielded triggered APs (C, bottom). 
FIGURE 5. Defective Ca2+ transients in Zmpste24-/- cardiomyocytes. (A) Left: Analysis of 
beat-to-beat response stability in isolated mouse ventricular myocytes subjected to increasing 
stimulation frequencies. Representative examples of calcium transients recorded in the 
presence of 5 mM extracellular Ca2+are shown. Irregular beat-to-beat responses start at lower 
frequencies in Zmpste24-/- cardiomyocytes. Right: The graph shows threshold frequencies (in 
Hz) for the induction of non-uniform beat-to-beat responses at the indicated Ca2+ 
concentrations. Responses were recorded in myocytes isolated from wild-type and Zmpste24-/- 
mice (12 cells from 6 mice of each genotype). (B) Top: Typical recordings of spontaneous 
calcium waves at the indicated Ca2+ concentrations. Bottom: Calcium dependency of the 
calcium wave frequency. Values are from 7 wild-type mice (n=15 cells) and 6 Zmpste24-/- mice 
(n=14 cells) (C) qPCR of heart tissue. (D) Western blot analysis of heart tissue. Representative 
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blots are shown and relative band intensity was quantified as described in Supplemental 
Methods.  *, p<0.05; **, p<0.01; ***, p<0.001. 
FIGURE 6. Reduced maximal sarcoplasmic reticulum Ca2+ uptake in Zmpste24-/- 
cardiomyocytes. SR calcium loading capacity in isolated ventricular myocytes. (A-C) Calcium 
loading measured as a function of the number of stimulation pulses used for SR loading. (A) 
Representative caffeine-induced currents recorded after SR reloading with the indicated 
number of stimulation pulses (p). Transient exposure to caffeine (CAF) was used to release SR 
calcium content before reloading and to measure loading after the train of stimulation pulses. 
(B) Time integral of caffeine-induced currents recorded after SR reloading with the indicated 
stimulation pulses. Data were obtained from 7 Zmpste24-/- and 8 wild-type myocytes (from n=5 
mice) exposed consecutively to 2 and 5 mM extracellular Ca2+. Time integrals were converted 
to amoles and normalized to cellular capacitance (in pF). (C) Effect of extracellular calcium 
concentration on the time integral of caffeine-induced current at steady-state (after ≥30 
stimulation pulses). (D-F) Calcium loading measured as a function of membrane potential. (D) 
Representative caffeine-induced currents recorded after SR loading with a 5s depolarization to 
the indicated membrane potentials. (E) Time integral of caffeine-induced current recorded in 
the presence of 2 mM extracellular Ca2+ after SR reloading at rest (-80 mV) and after 
depolarizing to the indicated voltage. Data were obtained from 8 Zmpste24-/- myocytes (n=5 
mice) and 9 wild-type myocytes (n=6 mice). (F) Mean calcium transient duration at half 
maximal amplitude (DHMA) recorded in myocytes paced at 0.5 Hz (17 wild-type and 18 
Zmpste24-/- myocytes from n=6 mice per group). *, p< 0.05.  
FIGURE 7. Impaired sarcoplasmic reticulum calcium release-dependent inactivation of 
L-type calcium currents in isolated Zmpste24-/- myocytes. (A) Protocol to measure the effect 
of SR calcium loading on ICa inactivation. SR calcium content was released with caffeine 
(CAF) and reloaded with a train of stimulation pulses (p). (B) Representative superimposed ICa 
recordings on p1 and p30. Currents were normalized to their peak values and fitted to a double 
exponential equation. (C) Dependency of time constant (tau) for fast ICa inactivation on 
indicated pulses. (D) Representative calcium transient (ΔF/F0) recordings from myocytes paced 
at 0.5 Hz (left) and calcium transient amplitude quantification (right). Indicated cardiomyocytes 
are from n=6 mice/genotype. *, p<0.05; **, p<0.01; ***, p<0.001. 
FIGURE 8. Abnormal localization of connexin43 in hearts of progeroid Zmpste24-/- mice 
and HGPS patients. (A, B) Double immunofluorescence of left ventricle sections from mice 
of the indicated gentoype and HGPS patients to detect N-Cadherin (N-Cadh, Left panels: 
green) and Cx43 (Middle panels: red). Right panels show merged images, with DAPI staining 
of nuclei (blue). (A) Cx43 lateralization was evident in Zmpste24-/- mice. Green arrows mark 
examples of intercalated disk areas (N-Cadh-positive). The white arrow in the Zmpste24-/- 
image marks an intercalated disk without Cx43 expression, and the red arrow in the wild-type 
image marks an intercalated disk with abundant Cx43 expression. (B) Representative images 
illustrating loss of Cx43/N-Cadh colocalization in HGPS heart. Green and white arrows are as 
in panel A. The red arrow marks a Cx43 positive area which does not colocalize with N-Cadh. 
(C) Zoom-in of a HGPS heart section showing predominat Cx43 expression near the nuclei and 
scarce Cx43/N-Cadh colocalization at the intercalated disks. (D) Automatic image 
segmentation of a HGPS heart section used for quantification of Cx43/N-Cadh colocalization. 
Green, red and dark-blue blob boundaries correspond to positive staining for N-Cadh, Cx43, 
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and nuclei, respectively. Cyan blob-boundaries represent areas showing Cx43/nuclei 
colocalization. (E) Percentage of Cx43/N-Cadh colocalization at the intercalated disks 
estimated by quantifying automatically-segmented images. Results are represented relative to 
wild-type (=100). N=3 wild-type and Zmpste24-/- mice, and N=2 HGPS patients were analyzed 
(n=5 sections per individual). *, p<0.001. White bars in the photomicrographs represent 50 µm. 
Baseline
v
A
B
5 min recovery from ISO
-0-
-1-
-0-
-1-
Last Week
First Week
Zmpste24-/-Wild-type
20 ms
Zmpste24-/-Wild-type
FIGURE 1
A
B
Po
in
t-t
o-
po
in
t
av
er
ag
ed
IB
I (
m
s)
10
First week
120
140
160
180
1 2 3 4 5 6 7 8 9ISO 10
140
180
220
260
ISO 1 2 3 4 5 6 7 8 9
Last week
min
Zmpste24-/-
C
500400300200100
400
800
1200
RR (ms)
O
cc
ur
re
nc
es
(n
)
Ti
m
e 
(m
in
)
0
15
5
20
10
RRn (ms)
R
R
n+
1 
(m
s)
100 200 300 400 500
100
200
300
400
500
First Week Last Week
D
Pr
em
at
ur
e
Ve
nt
ric
ul
ar
 
C
om
pl
ex
es 100
15
5
1200
500400300200100 RR (ms)
O
cc
ur
re
nc
es
(n
)
400
800
R
R
n+
1 
(m
s)
100
200
300
400
500
RRn (ms)100 200 300 400 500
WT Zmpste24-/-
SE 95% CI
WT (Last week) 
WT
WTZmpste24-/-
min
0
20
40
60
80
100
Time RR (ms)
*
*
*
*
**
Pe
rc
en
ta
ge
B
ea
ts First Week:      WT        Zmpste24-/-
Last Week:      WT        Zmpste24-/-
0
10
15
5
Ti
m
e 
(m
in
)
Po
in
t-t
o-
po
in
t
av
er
ag
ed
IB
I (
m
s) SE 95% CI
Zmpste24-/- (Last week) 
FIGURE 2
A 
Wild-type Zmpste24-/-
B C
P
TPeak
PQ QT
R
T90
Q S
QRS
D FE 
0
10
20
30
**
0,00
0,05
0,10
0,15
0.05
0.10
0.15
0,00
0,05
0,10
0,15
0.05
0.10
0.15
*
8
12
16
20
0
20
40
60
80
EF
 (%
) 
8 10 12 14 16 18 20
300
400
500
600
Age (weeks)
***
******
***
*
H
e
ar
t 
R
at
e
 (
B
.P
.M
)
H
ea
rt
ra
te
(B
.P
.M
.)
PQ
 (m
s)
300
400
500
600
Q
R
S 
(m
s)
Q
Tc
90
(m
s)
LV
ID
s
(in
de
xe
d/
tib
ia
 le
ng
th
)
LV
ID
d
(in
de
xe
d/
tib
ia
 le
ng
th
)
40
50
60
70
80
First Last
*
20
40
60
80
EF
 (%
)
148 10 12 2016 18
AGE (weeks) First Last
First Last First Last
Follow-up Follow-up
Follow-up
2
6
0
FIGURE 3
A B C
Wild-type
Zmpste24-/-
0 mV
0 mV
50
 m
V
100 ms
50
 m
V
100 ms
Wild-type
1 s50
 m
V
0
mV
0
mV
1 s5
0 
m
V
Zmpste24-/-
200 ms5
0 
m
V
Zmpste24-/-
0 mV
200 ms5
0 
m
V
0 mV
FIGURE 4
0
1
2
3
4
**
1 mM 2 mM 5 mM [Ca2+]
A
C
H
z
R
el
at
iv
e
m
R
N
A
le
ve
l
***
* **
1
2
3
4
D Wild-type Zmpste24-/-
100
50
50
CSQ
Tubulin
SERCA2a
kDa
Wild-type (n=6)
Zmpste24-/- (n=6)  
Wild-type (n=12) Zmpste24-/- (n=12)  
R
el
at
iv
e
pr
ot
ei
n
le
ve
l CSQ
0.5
1.0
1.5SERCA2a
0.5
1.0
1.5
*
0
1
ΔF/F0
10 s
Wild-type
Zmpste24-/-
0.25 Hz 0.5 Hz 1 Hz 2 Hz 4 Hz
0.25 Hz 0.5 Hz 1 Hz 2 Hz 4 Hz
B
20 s
[Ca2+]
1 mM
2 mM
5 mM
Δ
F/
F 0
0
4
1 mM 2 mM 5 mM
[Ca2+]
W
av
es
/ m
in
12
Wild-type (n=7)
Zmpste24-/- (n=6)  
Wild-type (n=3) Zmpste24-/- (n=3)  
4
8
Wild-type Zmpste24-/-
FIGURE 5
am
ol
/p
F
-80       -40  -30 -20       0    mV     
*
*
*
Wild-type (n=9)
Zmpste24-/- (n=8)
CAF
0
5
10
15
20
0
5
10
15
0 5 10 15 20
0
5
10
15
20
A
EB
D
Pulses 
am
ol
/p
F
*
*
**
*
C
5 s
F
2 
Wild-type (n=7)
Zmpste24-/- (n=8)
5 mM
5 s2p
A/
pF
-40 mV -30 mV -20 mV 0 mV
5 
2 
Wild-type (n=7)
*
am
ol
/p
F
Zmpste24-/- (n=8)
Wild-type Zmpste24-/-
0
800
*
D
H
M
A 
(m
s)
(n=17) (n=18)
200
400
600
[Ca2+]
2p
A/
pF
2p 5p 10p
1
1
2
5
1
15
2
2
4
6
8
10
CAF CAF
20
40
60
800
1 1 2
mM [Ca2+]
FIGURE 6
A Wild type Zmpste24-/-
p1
p30
p1
p30
I/I
M
ax
B
C D
-80
0
p1 p30p10p3
m
V
CAF
Wild-type (n=5) Zmpste24-/- (n=5)
1 3 10 30
Ta
u 
(m
s)
Pulse
number
*** **
10 
20 
30 
0 
Δ
F/
F 0 **
0
1.2
Wild-type Zmpste24-/-
(n=17) (n=18)
0 200ms 0 200ms
Wild-type
Zmpste24-/-
2s
0
1
Δ
F/
F 0
FIGURE 7
A
B
Zm
ps
te
24
-/-
W
ild
-ty
pe
Cx43N-Cadh
Merged
N-Cadh Cx43 DAPI
Cx43N-Cadh
Merged
N-Cadh Cx43 DAPI
Cx43
H
G
PS
N-Cadh
Merged
N-Cadh Cx43 DAPI
C
D
Merged
HGPS
Zoom-In x3 
Wild-type
Zmpste24-/- and HGPS
Mice (N=3)%
 C
x4
3
/ N
-C
ad
h
co
lo
ca
liz
at
io
n
(r
el
at
iv
e
to
 w
ild
-ty
pe
)
*
Human (N=2)
E
HGPS
Cx43 N-Cadh
FIGURE 8
